Alzheimer's and Parkinson's disease--overlapping or synergistic pathologies? (scientific article published in January 2002)

beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease

Q33947152

beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor

Q34099593

Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells

Q34780780

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes

Q35754459

Alzheimer disease A68 proteins injected into rat brain induce codeposits of beta-amyloid, ubiquitin, and alpha 1-antichymotrypsin

Q36433728

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

Q39173722

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity

Q42479244

Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein

Q42491661

Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils

Q43718666

The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease

Q48228304

Tau and transgenic animal models

Q58028348

Neuropathology in mice expressing human alpha-synuclein

Q74139704

P433

issue

P304

page(s)

3-5

P577

publication date

2002-01-01

P1433

published in

Trends in Molecular Medicine

Q15265842

P1476

title

Alzheimer's and Parkinson's disease--overlapping or synergistic pathologies?

P478

volume

Reverse relations

cites work (P2860)

Q36817223	A decade of tau transgenic animal models and beyond
Q77789894	A possible relationship between telomere length and markers of neurodegeneration in rat brain after welding fume inhalation exposure
Q46441393	Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease
Q21131066	Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease
Q35109104	Conditional human VEGF-mediated vascularization in chicken embryos using a novel temperature-inducible gene regulation (TIGR) system
Q35570834	Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies
Q31022390	Determination of the activation energy for unimolecular dissociation of a non-covalent gas-phase peptide: substrate complex by infrared multiphoton dissociation fourier transform ion cyclotron resonance mass spectrometry
Q38682342	Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease
Q37512025	Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro
Q34709035	Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease.
Q34096712	Neurodegeneration across stages of cognitive decline in Parkinson disease
Q33821316	Neuroproteomics as a promising tool in Parkinson's disease research
Q58028272	Primary support cultures of hippocampal and substantia nigra neurons
Q36525171	Redox proteomics in some age-related neurodegenerative disorders or models thereof
Q58277923	Signs of cross-seeding: aortic medin amyloid as a trigger for protein AA deposition
Q47335457	Similarity and Differences in Inflammation-Related Characteristics of the Peripheral Immune System of Patients with Parkinson's and Alzheimer's Diseases
Q58478214	Tauopathies and synucleinopathies: Do cerebrospinal fluid β-amyloid peptides reflect disease-specific pathogenesis?
Q35652325	The emerging role of infectious pathogens in neurodegenerative diseases
Q35723358	Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy.
Q36174650	Unveiling transient protein-protein interactions that modulate inhibition of alpha-synuclein aggregation by beta-synuclein, a pre-synaptic protein that co-localizes with alpha-synuclein

P356	DOI	10.1016/S1471-4914(01)02246-8
P698	PubMed publication ID	11796255